Evidence map›Paper›PMID 27642757›Full record

ArticlePLoS pathogens2016

Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.

Christopher S Eickhoff, Xiuli Zhang, Jose R Vasconcelos, R Geoffrey Motz, Nicole L Sullivan, Kelly O'Shea, Nicola Pozzi, David W Gohara, Jennifer R Blase, Enrico Di Cera and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Use ofFrontiers in microbiology · 2022
    Article
  4. Article
  5. Understanding CD8Trends in parasitology · 2019
    Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 2 countries.

Christopher S EickhoffDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Xiuli ZhangDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Jose R VasconcelosDepartamento de Biociências, Universidade Federal de São Paulo, Santos, Brazil.
R Geoffrey MotzDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Nicole L SullivanDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Kelly O'SheaDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.ORCID 0000-0002-8147-4480
Nicola PozziDepartment of Biochemistry and Molecular Biology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.ORCID 0000-0003-2309-7100
David W GoharaDepartment of Biochemistry and Molecular Biology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Jennifer R BlaseDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Enrico Di CeraDepartment of Biochemistry and Molecular Biology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
Daniel F HoftDepartment of Internal Medicine, Division of Infectious Diseases, Allergy & Immunology, Saint Louis University Medical Center, St. Louis, Missouri, United States of America.
University Medical Center · USUniversidade Federal de São Paulo · BR

Funding

STUDIES ON THROMBIN ALLOSTERYR01HL049413 · NHLBI · WASHINGTON UNIVERSITY · PI Enrico Di Cera · 2000 to 2026
$9.6M
Translational Research Skills Development CoreU54HL112303 · NHLBI · WASHINGTON UNIVERSITY · PI SADLER, J EVAN · 2012 to 2016
$8.8M
Studies on the anticoagulant properties of thrombinR01HL073813 · NHLBI · WASHINGTON UNIVERSITY · PI DI CERA, ENRICO · 2003 to 2015
$5.3M
TRYPANOSOMA CRUZI MUCOSAL &SYSTEMIC PROTECTIVE IMMUNITYR01AI040196 · NIAID · SAINT LOUIS UNIVERSITY · PI HOFT, DANIEL F. · 1999 to 2008
$2.7M
Development of Novel Chagas VaccinesR21AI099514 · NIAID · SAINT LOUIS UNIVERSITY · PI HOFT, DANIEL F. · 2012 to 2013
$413k
Trypanosoma cruzi Mucosal & Systemic Protective ImmunityR56AI040196 · NIAID · SAINT LOUIS UNIVERSITY · PI HOFT, DANIEL F. · 2010 to 2010
$375k
BIOPHYSICAL STUDIES OF THROMBINR29HL049413 · NHLBI · WASHINGTON UNIVERSITY · PI DI CERA, ENRICO · 1995 to 1999
–
NHLBI NIH HHS R01 HL049413NHLBI NIH HHS R01 HL073813NHLBI NIH HHS R29 HL049413NHLBI NIH HHS U54 HL112303NIAID NIH HHS R01 AI040196NIAID NIH HHS R21 AI099514NIAID NIH HHS R56 AI040196
6 · The paper itself

Abstract

Trypanosoma cruzi infection is controlled but not eliminated by host immunity. The T. cruzi trans-sialidase (TS) gene superfamily encodes immunodominant protective antigens, but expression of altered peptide ligands by different TS genes has been hypothesized to promote immunoevasion. We molecularly defined TS epitopes to determine their importance for protection versus parasite persistence. Peptide-pulsed dendritic cell vaccination experiments demonstrated that one pair of immunodominant CD4+ and CD8+ TS peptides alone can induce protective immunity (100% survival post-lethal parasite challenge). TS DNA vaccines have been shown by us (and others) to protect BALB/c mice against T. cruzi challenge. We generated a new TS vaccine in which the immunodominant TS CD8+ epitope MHC anchoring positions were mutated, rendering the mutant TS vaccine incapable of inducing immunity to the immunodominant CD8 epitope. Immunization of mice with wild type (WT) and mutant TS vaccines demonstrated that vaccines encoding enzymatically active protein and the immunodominant CD8+ T cell epitope enhance subdominant pathogen-specific CD8+ T cell responses. More specifically, CD8+ T cells from WT TS DNA vaccinated mice were responsive to 14 predicted CD8+ TS epitopes, while T cells from mutant TS DNA vaccinated mice were responsive to just one of these 14 predicted TS epitopes. Molecular and structural biology studies revealed that this novel costimulatory mechanism involves CD45 signaling triggered by enzymatically active TS. This enhancing effect on subdominant T cells negatively regulates protective immunity. Using peptide-pulsed DC vaccination experiments, we have shown that vaccines inducing both immunodominant and subdominant epitope responses were significantly less protective than vaccines inducing only immunodominant-specific responses. These results have important implications for T. cruzi vaccine development. Of broader significance, we demonstrate that increasing breadth of T cell epitope responses induced by vaccination is not always advantageous for host immunity.

Indexed as

AnimalsAntigens, ProtozoanCD8-Positive T-LymphocytesChagas DiseaseEpitopes, T-LymphocyteFemaleGlycoproteinsHumansImmunityImmunodominant EpitopesMiceMice, Inbred BALB CNeuraminidaseProtozoan VaccinesTrypanosoma cruziVaccines, DNAAntigens, ProtozoanEpitopes, T-LymphocyteGlycoproteinsImmunodominant EpitopesNeuraminidaseProtozoan Vaccinestrans-sialidaseVaccines, DNA

Identifiers

PMID27642757
PMCPMC5028030
OpenAlexW2521689936

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.